Metraipolis › archive › dc_316634ff541f
Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes — Europe PMC PMID:41053997
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41053997
- DOI
- 10.1111/dom.70164
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T13:21:46.799Z
- SHA-256 of the archived text
55a109d37b1c415d124206c9e98eac3f2f2513b5ac83b807297cd21fe5f13001- Stable URL of this page
https://metraipolis.com/documento/dc_316634ff541f
How to cite
Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes — Europe PMC PMID:41053997 — Europe PMC (en), https://europepmc.org/article/MED/41053997 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_316634ff541f (Metraipolis archive dc_316634ff541f, sha256 55a109d37b1c415d124206c9e98eac3f2f2513b5ac83b807297cd21fe5f13001)
BibTeX
@misc{dc316634ff541f,
title = {Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes — Europe PMC PMID:41053997},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41053997},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_316634ff541f; sha256 55a109d37b1c415d124206c9e98eac3f2f2513b5ac83b807297cd21fe5f13001},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41053997. Agents can read the archived copy with the MCP tool read_document.